Meet the Team
The Steering Committee provides overall scientific leadership, direction, and oversight. Its members are responsible for overseeing progress and coordination between the different work strands, operations, administration, budget, and interaction with knowledge users. They are accountable for the delivery of the scientific milestones and the effective administration of the project.
Dr Hanns Lochmüller leads the NMD4C network. He is a neurologist and clinical academic specializing in neuromuscular disorders. He is Senior Scientist at the Children’s Hospital of Eastern Ontario (CHEO) Research Institute and Professor of Neurology at the University of Ottawa and the Division of Neurology at The Ottawa Hospital.
Dr James Dowling is Associate Professor of Paediatrics and Molecular Genetics at the University of Toronto, and a Neurologist and Senior Scientist at the Hospital for Sick Children. He represents paediatric NMDs as a member of the NMD4C Steering Committee, leads on genomics education and curriculum, and participates in trial coordination.
Dr Jodi Warman Chardon is Assistant Professor of Neurology at University of Ottawa, Director of the Ottawa Hospital Neuromuscular Centre and co-Director of the uOttawa Centre for Neuromuscular Disease. She represents adult NMDs on the NMD4C Steering Committee and participates in genomics education.
Dr Rashmi Kothary is the Deputy Scientific Director and Senior Scientist at the Ottawa Hospital Research Institute (OHRI). He represents basic science as a member of the NMD4C Steering Committee.
Stacey is CEO of Muscular Dystrophy Canada (MDC). She represents MDC on the NMD4C steering committee. Stacey holds degrees in nursing and non-profit business management as well as a Human Resources Certificate. She has worked in the not-for-profit sector for over 20 years.
Dr Bernard Brais is Professor of Neurology and Human Genetics at McGill University in Montreal and co-director of the Montreal Neurological Institute’s Rare Neurological Diseases Group. His lab has focused on identifying new genes and mutations that cause hereditary diseases that are more prevalent in the French Canadian population of Quebec due to founder effects.
Dr Craig Campbell is affiliated with the Thames Valley Children’s Centre and the Pediatric Neurophysiology Laboratory at Children’s Hospital London Health Sciences Centre. He is a Full Professor in Pediatrics, Clinical Neurological Sciences and Epidemiology at Western University and a Scientist at the Children’s Health Research Institute.
Dr Cynthia Gagnon is a professor at the School of Rehabilitation at the University of Sherbrooke and a researcher at the Centre de recherche Charles-Le Moyne-Saguenay-Lac-St-Jean sur les innovations en santé. Her work aims at improving clinical care and speeding up trial readiness in the most prevalent neuromuscular diseases in Canada. Within NMD4C, Cynthia is lead for knowledge translation.
Dr. Daria Wojtal is the Director of Research at Muscular Dystrophy Canada. Currently at MDC Daria oversees Research Investments including the design, implementation and monitoring of comprehensive business strategies, budgets, plans and procedures related to the research portfolio and its funding opportunities as well as the generation and review of medical and scientific educational content.
Dr. Homira Osman is a representative of Muscular Dystrophy Canada, where she is the Director of Knowledge Translation & External Engagement. Her background is in clinical audiology, in which she researched the interplay of auditory and cognitive processes in speech perception. She has also completed training in knowledge translation.
Dr Hugh McMillan is an Associate Professor of Pediatrics at the University of Ottawa, a Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario (CHEO) and a Clinical Investigator at the CHEO Research Institute.
Dr Kathryn Selby is Clinical Assistant Professor at the University of British Columbia, Medical Director of the pediatric neuromuscular program of BC and the Yukon, and an investigator at BC Children’s Hospital Research Institute.
Dr Lawrence Korngut is a neurologist, clinical neurophysiologist and Director of the Calgary Neuromuscular Program and the Calgary ALS and Motor Neuron Disease Clinic. He is the former chair of the CAN-NMD network and is involved in the NMD4C work on trial capacity building.
Dr Maryam Oskoui is an Associate Professor in the Departments of Pediatrics and Neurology and Neurosurgery at McGill University and Associate Member of the Department of Epidemiology and Biostatistics.
Nicola is the Director of Research and Advocacy at Jesse’s Journey and the mom of a boy with Duchenne muscular dystrophy. Educated in genetics and molecular biology, she spent the last 15 years working in biotech and the pharmaceutical industry in areas of infectious disease and hepatology, and later spent most of her time in medical affairs focused in neurology and rare disease.
Dr Reshma Amin is Associate Professor at the University of Toronto; Respirologist and Sleep Physician at SickKids; and Associate Scientist, Child Health and Evaluative Sciences at SickKids Research Institute. Within NMD4C Reshma is working on the development of clinical care guidelines for NMDs and patient advocacy training modules for NMD.
Teresa Buffone leads the Ottawa-Gatineau Myotonic Dystrophy Support Group and is an advocate for the US Myotonic Dystrophy Foundation. Within NMD4C she works with MDC and other knowledge user representatives on knowledge translation to the patient community.
Dr. Erin Beattie is the Network Manager for NMD4C. She graduated with a BSc in microbiology & immunology and an MSc in pharmacology from Dalhousie University, and a PhD in laboratory medicine & pathobiology from the University of Toronto.
James is the NMD4C Communications Coordinator. He writes and coordinates all network communications including news updates, the monthly newsletter, the website, and the social media (Twitter, Facebook, and LinkedIn). He also manages memberships and liaises with the many people and sites involved in the network.
Dr. Gonorazky co-leads the NMD4C’s work in developing a clinical research curriculum for neuromuscular fellowship programs. Dr. Gonorazky graduated from medical school at University of Buenos Aires. He completed his residency in adult neurology and afterward he did his specialization in adult neuromuscular disorders. He continued his studies in paediatric neuromuscular disorders at Sickkids in 2014 and became a permanent Staff in 2019.
Dr. Izenberg’s clinical focus is in the diagnosis and management of patients with neuromuscular and neurological disease. He has particular interest in management of motor neuron diseases (including ALS and SMA), myopathy, myasthenia gravis, peripheral neuropathy, as well as urgent neurology.
Perry Esler is Executive Director of Jesse’s Journey, Canada’s largest Duchenne-focused charity. He works as part of the NMD4C knowledge user group with a focus on knowledge translation for Duchenne families.
Valérie Gagné-Ouellet is a knowledge broker for NMD4C, translating evidence into action in health care. She has a Ph.D. in biochemistry and functional genomics from the Université de Sherbrooke in the field of epigenetics and fetal metabolic programming.
Kimberly Amburgey received her Master’s degree in genetic counseling from the University of Pittsburgh. She is currently the genetic counselor in the Pediatric Neuromuscular Clinic at the Hospital for Sick Children in Toronto. Kimberly is an instructor in the Department of Molecular Genetics at the University of Toronto. She also a member of the Canadian rare disease organization, Canadian Gene Cure Advanced Therapies for Rare Disease (Can-GARD).
Rhiannon graduated from Western University with a Bachelor’s degree in biology. She is the project manager for the Pediatric Neuromuscular Research Program at Children’s Hospital – London Health Sciences Centre, with 13 years experience with the team. Her work within the NMD4C will focus on the development of a clinical trial network and comprehensive research curriculum.
Dr. Hodgkinson is the National Program Manager for the Canadian Neuromuscular Disease Registry, where she oversees the scientific management and coordination of national patient registries in neuromuscular disease.
As National Director of Operations Josh Lounsberry oversees all aspects of the Canadian Neuromuscular Disease Registry including business operations, research planning, and strategic partnerships. He has over a decade managing teams in medical research, is a published researcher, and has an MBA.
With more than 13 years of experience in both Canada and the UK, Rochelle ten Haaf is passionate about working in the non-profit sector. Her focus is to help health care charities turn consideration into action through the power of marketing and communications and she brings the same enthusiasm to defeat Duchenne muscular dystrophy at Jesse’s Journey.